March 26, 2020 Biotech’s balancing act amid Covid-19 delays A Vantage analysis suggests which small biotechs might seriously have to rethink R&D spending plans in the wake of Covid-19.
December 19, 2019 Gene therapy clinical holds take centre stage An analysis of company disclosures reveals a sharp rise in US FDA-imposed halts on clinical work involving gene therapies.
March 29, 2018 Snippet roundup: Edge blunted by trial's end, but Esperion soars on bempedoic acid hopes
